Environmental responsibility and biopharmaceutical companies: Developing a competitive strategy

Author

Li, Wei ; Yu, Ruixiang

Author_Institution

Sch. of Econ. & Manage., China Univ. of Geosci., Wuhan, China

Volume

3

fYear

2011

fDate

13-15 May 2011

Firstpage

51

Lastpage

54

Abstract

Corporate environmental responsibility (CER) is now on the corporate and political agenda in China. The objective of this study is to determine the relevance of environmental aspects for China biopharmaceutical companies. This paper presents a new perspective which calls for an integration of CER into the business strategy as a source of competitive advantages in the biopharmaceutical companies. We also introduce an Internal Responsibility System (IRS) to meet company´s environmental responsibilities.

Keywords

competitive intelligence; corporate social responsibility; environmental factors; pharmaceutical industry; CER; China biopharmaceutical company; IRS; business strategy; competitive advantages; competitive strategy; corporate environmental responsibility; environmental aspects; internal responsibility system; political agenda; Biotechnology; Companies; Ethics; Green products; Manufacturing; Biopharmaceutical companies; CER; Competitive strategy; IRS;

fLanguage

English

Publisher

ieee

Conference_Titel

Business Management and Electronic Information (BMEI), 2011 International Conference on

Conference_Location

Guangzhou

Print_ISBN

978-1-61284-108-3

Type

conf

DOI

10.1109/ICBMEI.2011.5918038

Filename

5918038